Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study
Titel:
Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study
Auteur:
Bisschop, C. Dijk, T. H. van Beukema, J. C. Jansen, R. L. H. Gelderblom, H. Jong, K. P. de Rutten, H. J. T. de Velde, C. J. H. van Wiggers, T. Havenga, K. Hospers, G. A. P.